Why is Ajanta Pharma falling/rising?

As of 15-Jul, Ajanta Pharma Ltd. is experiencing a rise in its stock price, currently at Rs 2,707.00, reflecting an increase of Rs 53.0 or 2.0%. The stock has shown strong performance recently, gaining 4.44% over the last three days and outperforming its sector by 0.75% today. It reached an intraday high of Rs 2,711.85, indicating positive momentum. Furthermore, the stock has generated a return of 20.54% over the past year, significantly surpassing the market's return of 0.37%. The company benefits from high management efficiency, evidenced by a return on equity (ROE) of 22.06%, and a low debt-to-equity ratio, which contributes to investor confidence. Additionally, high institutional holdings at 26.35% suggest that informed investors are backing the stock.
In the broader market context, Ajanta Pharma's short-term return of 4.02% over the past week contrasts sharply with the Sensex's decline of 1.36%, highlighting its relative strength in a challenging market environment. While the stock has underperformed year-to-date with a decline of 8.11%, its long-term performance over three and five years shows substantial gains of 124.21% and 203.59%, respectively, compared to the benchmark's returns of 53.59% and 129.03%. This indicates that despite some short-term volatility, Ajanta Pharma has maintained a strong overall performance, attracting increased investor participation and liquidity, which further supports its rising stock price.